HOME >> MEDICINE >> NEWS
Pacemaker for larynx allows patients to breathe easier

Doctors at Vanderbilt University Medical Center have developed a new implantable device that helps patients with paralyzed vocal folds breathe on their own.

The new device for bilateral paralysis of the larynx is an Implantable Pulse Generator (IPG) that allows a patient to speak and breathe normally. The device was recently implanted, for the first time ever in the United States, in a Missouri woman.

"We are excited about the possibilities with this electrical pacing device," said David L. Zealear, Ph.D., associate professor of Otolaryngology and director of research in the department. "The idea is to restore the opening function of the larynx to allow inhaling and exhaling necessary to normal breathing. We are able to restore that function."

With the device, Zealear says, an electrode is inserted next to the opening muscle of the larynx sandwiched between the cricoid cartilage and the muscle. "It involves electrical stimulation of the critical laryngeal muscle that has been paralyzed. The stimulation is done at the precise moment that the patient inhales, allowing the patient to take a breath," Zealear said. The lead wire from the electrode is then brought subcutaneously through a tunnel to an incision below the clavicle. A pocket is made at that incision site and the stimulator is placed in that pocket. It can be re-programmed through the skin by using a microprocessor, Zealear said. "When the stimulus is discontinued, the muscles passively relax back to their midline position to allow normal voice production and airway protection."

Zealear says about 6,000 patients are stricken with bilateral laryngeal paralysis each year in the United States. The condition is created primarily when the two nerves that serve the larynx become paralyzed due to neck surgery. "Both the opening and closing functions are lost on both sides. The patient can not breathe and is in a life-threatening situation. For acute paralysis, the patient must have an emergen
'"/>

Contact: Matt Scanlan
matt.scanlan@mcmail.vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
21-Sep-1999


Page: 1 2 3

Related medicine news :

1. Pacemakers could protect patients with epilepsy from sudden unexplained death
2. Cells of larynx may have significant immune functions
3. Improving the quality of life for larynx cancer patients
4. Prototype system developed by Wright State computer engineer allows blind to see
5. Combined kidney and bone marrow transplantation allows patients to discontinue anti-rejection drugs
6. New laser treatment allows patients to swallow and breath easier
7. Hormonal treatment improves survival in high-risk prostate cancer patients
8. Study finds that coordinating care of chronically ill patients does not increase liability
9. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
10. Optical technique identifies vulnerable plaques in cardiac patients
11. NHS target driven culture is failing patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pacemaker for larynx allows patients breathe easier

(Date:4/27/2015)... (PRWEB) April 27, 2015 Covenant Care, ... nationwide, has rolled out its “Enhanced Dining” service with ... foods developed with input from residents, patients and families ... and the redesign of its dining rooms so that ... the quality of life for our residents is our ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 The ... both inpatient and outpatient therapy facilities that provide physical, ... years to 2015, the industry has experienced revenue growth ... acceptance of the benefits of physical therapy services. The ... helped support industry revenue growth during the period because ...
(Date:4/26/2015)... Indiana Fiber Network, LLC (IFN), the leading Indiana ... Company has selected IFN as a fiber transport provider. ... Mutual Insurance Company states: “IFN’s broadband fiber solution created ... We were interested in building entrance and ... ensure we achieved both. ” , According ...
(Date:4/26/2015)... India Network Foundation, a non-profit organization in ... to the Asian Indian community in the United States ... than two decades. The India News Network Digest of ... the world with the latest news items from India, ... Law Forum Digest, edited and contributed by Sheela Murthy, ...
(Date:4/26/2015)... The grand celebration got off to a festive start with ... Deb then introduced Sandy Valentine, the wife of CCAR’s Executive ... his Walk for Recovery on the Appalachian Trail. ... gratitude to the volunteers via video. Board President Tom Kirk ... CCAR’s mission. Volunteer Manager Conrad Sienkiewicz read the names ...
Breaking Medicine News(10 mins):Health News:Covenant Care Rolls Out "Enhanced Dining" Offering Restaurant Style Experience To Residents, Patients & Families 2Health News:Physical Therapy Rehabilitation Centers in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Physical Therapy Rehabilitation Centers in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 3Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 2Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 3Health News:The Connecticut Community for Addiction Recovery (CCAR) honors its volunteers during National Volunteer Recognition Week. 2
(Date:4/24/2015)... -- Hospira, Inc. (NYSE: HSP ), ... spoke about the importance of extrapolation in bringing biosimilars ... annual European Biosimilars Group conference in London ... publication of a pivotal white paper titled, "Why ... biosimilars." Speaking at the EGA conference, ...
(Date:4/23/2015)... , April 24, 2015  AbbVie (NYSE: ABBV ... Administration (FDA) has accepted its New Drug Application (NDA) ... two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), ... of adults with chronic genotype 4 (GT4) hepatitis C ... first all-oral, interferon-free therapy being evaluated by the FDA ...
(Date:4/23/2015)... 23, 2015 Once again, BeaconMedaes is meeting ... to patient safety. BeaconMedaes, priority is to ... disease. The next generation Zone Valve Box ... are now mounted in the assembly, allowing for ease ... ceiling tiles potentially releasing dust spores and other bacteria ...
Breaking Medicine Technology:Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7BeaconMedaes launches new Zone Valve Box Assembly 2
Cached News: